2 completed, 1 active not recruiting, 1 recruiting. 2 Phase 3, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Antiretroviral Combinations: new trials by email Literature Review of Antiretroviral Combinations trials Research Report on Antiretroviral Combinations
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1 ISL/LEN, Antiretroviral Combinations - HIV-1-Infection | Phase 3 | Active not recruiting | Gilead Sciences | 600 | 2024-10-08 | 2026-05-29 |
| Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals cabotegravir/rilpivirine (600mg/ 900mg), Antiretroviral Combinations - HIV-1-infection, Non-Adherence, Medication | Phase 3 | Recruiting | Chang Gung Memorial Hospital | 40 | 2024-07-19 | 2024-08-23 |
| Contribution of Dolutegravir to Obesity and Cardiovascular Disease Dolutegravir 50 MG, Antiretroviral/Anti HIV - HIV-1-infection, Antiviral Drug Adverse Reaction | Phase 4 | Completed | Augusta University | 10 | 2020-09-17 | 2023-07-27 |
| Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial. Valganciclovir, Antiretroviral Combinations - Kaposi Sarcoma, Human Immunodeficiency Virus | Phase 2 | Completed | National Institute of Cancerología | 40 | 2015-10-01 | 2022-01-27 |
Acquired Immunodeficiency Syndrome (1) · Body Weight Changes (1) · Cardiovascular Abnormalities (1) · HIV-Associated Lipodystrophy Syndrome (1) · Immune Reconstitution Inflammatory Syndrome (1) · Medication Adherence (1) · Sarcoma, Kaposi (1) · Vascular Diseases (1)
Augusta University (1) · Chang Gung Memorial Hospital (1) · Gilead Sciences (1) · National Institute of Cancerología (1)
Taiwan (2) · United States (2) · Argentina (1) · Australia (1) · Germany (1) · Japan (1) · Mexico (1) · Netherlands (1) · Poland (1) · Puerto Rico (1) · South Africa (1) · Spain (1) · Switzerland (1) · Thailand (1) · United Kingdom (1)
Jonell B Poe, MPAS (1) · Nan-Yu Chen, MD, PhD (1)